Company Filing History:
Years Active: 2000
Title: Innovations of Soo Il Jung in Immunosuppressant Research
Introduction
Soo Il Jung is a notable inventor based in Kyonggi-do, South Korea. He has made significant contributions to the field of immunology through his innovative research and patents. His work focuses on the use of natural compounds for therapeutic applications, particularly in the context of immune response modulation.
Latest Patents
Soo Il Jung holds a patent for the "Use of rosmarinic acid and derivatives thereof as an immunosuppressant." This invention relates to the application of rosmarinic acid and its derivatives as immunosuppressive agents. The patent outlines how these compounds specifically inhibit the binding of ligand peptides to the Lck SH2 domain, disrupt Lck-mediated signal transduction in T cells, and suppress cytokine gene expression. These properties make rosmarinic acid and its derivatives promising candidates for the treatment, prevention, and diagnosis of graft rejection, graft-versus-host disease (GVHD), autoimmune diseases, and inflammatory conditions. He has 1 patent to his name.
Career Highlights
Soo Il Jung is affiliated with the Mogam Biotechnology Research Institute, where he conducts his research. His work has garnered attention for its potential applications in medical science, particularly in improving transplant outcomes and managing autoimmune disorders.
Collaborations
He collaborates with esteemed colleagues, including Eun Mi Hur and Young Bong Choi, who contribute to the research efforts at the institute. Their combined expertise enhances the quality and impact of their scientific endeavors.
Conclusion
Soo Il Jung's innovative research in the use of rosmarinic acid as an immunosuppressant highlights the potential of natural compounds in medical applications. His contributions to the field of immunology are significant and pave the way for future advancements in treatment strategies.